Circulate
Seattle
About Circulate
Circulate provides Therapeutic Plasma Exchange (TPE) treatments that remove inflammatory and disease-related substances from the bloodstream. The company offers an end-to-end solution enabling clinics and doctors' offices to deliver fully managed TPE treatments without requiring specialized equipment or staff. Its proprietary technology is FDA cleared and supported by clinical research, showing potential to slow age-related biological processes and treat autoimmune conditions. Circulate focuses on evidence-based approaches that allow patients to experience therapeutic effects relatively quickly compared to conventional treatments. The service integrates science, clinical management, and patient care to facilitate healthier aging and address age-related diseases.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $12.0M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: circulate.health
- Phone: +1 206-289-0097
Industries & Categories
Health Care, Outpatient Care, Therapeutics, Wellness
Social Profiles
Canonical: https://fsome.com/organization/circulate-19299 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.